1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc
XNAS: BEAM
25.49 0.33 (1.31%)
1.5M
XNAS Volume

XNAS 16 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 17 analysts

Beam Therapeutics Inc has a share price target of US$ 50, revenue growth forecast of -65.3%, and profit growth estimate of -497.2% for FY26, based on top 17 analyst calls.